About Vivli AMR Open Data Reuse Data Challenge
Vivli AMR Open Data Reuse Data Challenge
About this Collection
The Vivli AMR Open Data Reuse Data Challenge utilised antimicrobial resistance (AMR) surveillance data, collected by the pharmaceutical industry and made available within the AMR Register. Launched as a catalyst for the inventive reutilization of the wealth of surveillance data available, the resulting solutions were diverse, impactful and innovative, proposing groundbreaking advancements and tools for use in AMR surveillance. This Collection brings together articles written by a selection of finalist and award-winning teams who participated in the challenge. More details about the data challenge can be found here.
Collection Advisors
Rebecca Li
Rebecca Li, PhD, is the CEO of Vivli and on faculty at the Center for Bioethics at the Harvard Medical School. She acts as the lead for the Vivli AMR Register. Previous to her current role she was the Executive Director of the MRCT Center of Brigham and Women’s Hospital and Harvard for over 5 years and remains a Senior Advisor at the Center. She has over 30 years of experience spanning the entire drug development process with experience in Biotech, Pharma and CRO environments with a focus in clinical trials. She completed a Fellowship in 2013 in the Division of Medical Ethics at Harvard Medical School. She earned her PhD in Chemical and Biomolecular Engineering from Johns Hopkins University.
Patricia A. Bradford
Patricia Bradford is the owner of Antimicrobial Development Specialists LLC, a consulting company that focuses on the late-stage development of antibiotics. Prior to this she has held positions in antibiotic research for AstraZeneca, Novartis, Wyeth Pharmaceuticals and Lederle Laboratories and has worked on the successful development and approvals for several antibacterial products. Dr. Bradford is fellow in the American Academy of Microbiology and has over 100 publications in peer-reviewed scientific journals. She is also an active participant with the subcommittee on Antimicrobial Susceptibility Testing of the Clinical Laboratory Standards Institute. Dr. Bradford received a Ph.D. in Medical Microbiology from Creighton University and completed a post-doctoral fellowship in b-lactamase research.
Collection Advisors
Rebecca Li
Rebecca Li, PhD, is the CEO of Vivli and on faculty at the Center for Bioethics at the Harvard Medical School. She acts as the lead for the Vivli AMR Register. Previous to her current role she was the Executive Director of the MRCT Center of Brigham and Women’s Hospital and Harvard for over 5 years and remains a Senior Advisor at the Center. She has over 30 years of experience spanning the entire drug development process with experience in Biotech, Pharma and CRO environments with a focus in clinical trials. She completed a Fellowship in 2013 in the Division of Medical Ethics at Harvard Medical School. She earned her PhD in Chemical and Biomolecular Engineering from Johns Hopkins University.
Patricia A. Bradford
Patricia Bradford is the owner of Antimicrobial Development Specialists LLC, a consulting company that focuses on the late-stage development of antibiotics. Prior to this she has held positions in antibiotic research for AstraZeneca, Novartis, Wyeth Pharmaceuticals and Lederle Laboratories and has worked on the successful development and approvals for several antibacterial products. Dr. Bradford is fellow in the American Academy of Microbiology and has over 100 publications in peer-reviewed scientific journals. She is also an active participant with the subcommittee on Antimicrobial Susceptibility Testing of the Clinical Laboratory Standards Institute. Dr. Bradford received a Ph.D. in Medical Microbiology from Creighton University and completed a post-doctoral fellowship in b-lactamase research.
Collection Advisors
-
Rebecca Li
-
Patricia Bradford